Celsion Stock Price

0.07 (2.98%)
Upgrade to Real-Time
Regular Market
Volume 31,490
Bid Price 2.39
Ask Price 2.43
News -
Day High 2.44


52 Week Range


Day Low 2.26
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Celsion Corporation CLSN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 2.98% 2.42 14:43:37
Open Price Low Price High Price Close Price Prev Close
2.27 2.26 2.44 2.35
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
160 31,490 $ 2.35 $ 74,109 - 0.3116 - 7.68
Last Trade Time Type Quantity Stock Price Currency
14:47:09 66 $ 2.40 USD


Draw Mode:

Celsion Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.18M 7.10M 7.06M $ 500.00k $ - -5.79 -0.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 125.00k 7.40%

more financials information »

Celsion News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLSN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.602.60012.23012.3741,224-0.18-6.92%
1 Month3.023.35942.23012.7447,026-0.60-19.87%
3 Months4.537.682.23015.37341,376-2.11-46.58%
6 Months0.72997.680.31162.16488,7511.69231.55%
1 Year1.117.680.31161.41845,3131.31118.02%
3 Years2.067.680.31161.922,587,3080.3617.48%
5 Years3.507.680.31162.221,912,788-1.08-30.86%

Celsion Description

Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.